This post was written by Minyanville contributor Sean Udall.
Aglient Technologies (NYSE: A) just reported this morning and again the company is simply one of the best tech and science shops, which few talk about.
It guided lower but it was minor compared to most tech names of late. Also, A's stock is down about 35% vs. a space down 50% with many names down 65-80% off of highs so the value and durable earnings quality of A is providing some cover.
Circling back to market dynamics, I've contended many times about my view on the markets' four key problems and the difficulty in gaining traction while these are not yet solved. I won't reiterate this whole theme; however, it is noteworthy that we are so willing to spend $350 billion of the TARP while not addressing FAS 157 as well as the uptick rule. Changing these two issues costs the world "nothing". And they are either done with a "pen stroke or a few key strokes".
Yet changing these rules -- might just save the world billions in additional spending, doesn't require Congressional approval, doesn't require the Fed to expand the balance sheet, and lastly doesn't require more rates cuts which could prove quite inflationary.
Last updated: July 06, 2009: 04:10 AM
Hot Stocks
DailyFinance Headlines
- Is the "wrong direction" the "right direction" for investors?
- Should car companies be considered "strategic" national interests?
- Surprise Hits: Netbooks are the future of computing
- Surprise Hits: Dippin' Dots -- the ice cream of the future has finally arrived
- Declaration of Independence from Wall Street
Latest from BloggingBuyouts
- Investors pressure private equity funds to cut fees
- Will an IPO bring more transparency to KKR?
- Will FDIC's new rules for buying failed banks deter private-equity investors?
- Blackstone anticipates recovery in Europe
- Carlyle, KKR, JC Flowers and others eye Nan Shan Life
TheFlyOnTheWall.com Headlines
BioHealth Investor Headlines
- Discovery Labs setback exacerbated by potential cash crunch (DSCO)
- Discovery Labs… Lessons of FDA Changes For Others To Heed (DSCO)
- BioSante’s Acquisition of Cell Genesys, Actual Beauty in Biotech Zombies (BPAX, CEGE)
- Why Acorda shares are sinking after seemingly positive development news (ACOR, BIIB)
- Biotech Stocks On the Move Early Wednesday (AMAG, MYGN, SPPI, NVAX)
WalletPop Headlines
- Book review: 'Gimme Shelter'
- Little pink (collar) pills: Pharmacists top list of best-paying jobs for women
- Spoiled brat not happy with his 16th birthday present
- Penny-Pinching Picnics: Summer party tips that will save you money
- Live, from Walt Disney World, it's the Obamabot!
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Money
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Report
- DJIA
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Dow Jones Industrial Average
- AMT
- Car Insurance
- Common Tax Filing Mistakes
- Credit Score Calculator
- Crude Oil Prices
- DailyFinance
- Deals
- ETF Investing
- Financial Crisis
- GOOG
- Health Insurance
- Historical Stock Prices
- Home Insurance
- Income Tax
- Life Insurance
- Madoff
- Naked Nike Ad
- Online Tax Filing
- Pig Flu
- Recession
- Resume Builder
- Stock Brokers
- Stock Ticker
- Tax Advice
- Tax Audit
- Tax Credit
- Tax Deductions
- Tax Forms
- Tech News
WalletPop Headlines
Other Weblogs Inc. Network blogs you might be interested in:










